The COVID-19 pandemic has spread to more than 33 million people worldwide, sending the healthcare industry racing to find a safe and effective vaccine. With over 42 candidates now in human trials, the conversation is evolving from not only when a vaccine(s) will be available, but also how those vaccines will be distributed to effectively halt the spread of the virus. The episode opens with a discussion of the changes to the traditional vaccine development process being undertaken to meet the objectives of Operation Warp Speed and (05:11) the potential long-term impacts it could have on future vaccines. At (07:18), the conversation shifts to a discussion of potential challenges for local health organizations developing and executing COVID-19 vaccine distribution plans – from storage requirements (08:39), to the need for consecutive doses (10:15), to difficulties of reaching underserved patients (10:54). Innovative partnerships (12:00) will be critical in ensuring widespread distribution, the spread of public health information, and ensuring patient compliance (13:00). Capacity planning (13:17) and provider recruitment (13:38) will be critical as demand and scope change from phase to phase of distribution. The conversation closes (14:13) with a discussion of how public health providers, health plans, and other industry players might encourage adoption of future COVID-19 vaccines, the importance of building public trust in the safety of the vaccines being brought to market, spreading information on when and how to receive the vaccine (16:28), and communicating the long-term efforts that will be required to bring the virus under control (18:17). Based on public opinion polls (19:50), there will certainly be a need for public education on (21:03) potential side effects, (21:55) the risk/benefit ratio, and (23:05) the long-term safety protocols in place in order to ensure widespread adoption of a COVID-19 vaccine.
MedTech Goes Digital
Trending News EU – 11 May 2023
Trending News US – May 4, 2023
DEI & You – Overcoming Data Biases to Advance Health Equity
Trending News US – April 20, 2023
Trending News EU – 13 April 2023
Life Sciences, Health Systems, and Healthcare Tech: Working Together to Deliver Better Patient Outcomes
What if there was a digital tool that could close the loop between patient and provider, using data to improve diagnosis and treatment? Read how Vynamic addressed that question for a Life Sciences client by providing the leadership to make this concept a reality.
- Life Sciences
- Healthcare Technology
Establishing an Agile Commercial Innovation Hub for a Big Pharma That Wants to Operate More Like Healthcare Tech
A global Life Sciences company wanted to reinvent its commercial business model and disrupt the overall healthcare industry by operating more like a nimble biotech. To do so, the company engaged with Vynamic to develop an innovation capability that would allow it to run agile experiments and quickly learn from both the successes and failures while identifying potential solutions. Read how Vynamic established the value proposition, framework, and team structure to enable this innovative capability, while also providing the overall program monitoring and control.
- Life Sciences
- Operating Model & Org Design©
Market Access Capability Analysis & Process Mapping for a Cell and Gene Therapy Biotech
A pre-commercial Cell and Gene Therapy client was preparing for the launch of its first product. Read how the newly formed Market Access team contacted Vynamic to assist with strategic planning and process development to support an innovative, outcomes-driven approach for value based contracting arrangements.
- Life Sciences
Want to learn more? Get in Touch!
Contact our team to learn more about how we can help your needs.